Abstract
Dipeptidyl peptidase (DPP)-IV inhibitors are a new approach to the treatment of type 2 diabetes. DPP-IV is a member of a family of serine peptidases that includes quiescent cell proline dipeptidase (QPP), DPP8, and DPP9. DPP-IV is a key regulator of incretin hormones, but the functions of other family members are unknown. To determine the importance of selective DPP-IV inhibition for the treatment of diabetes, we conducted molecular docking studies on clinical inhibitors of DPP-IV.
References
Knudsen LB. (2004) J. Med. Chem. 47: 4128-4134.
Drucker, DJ. (2001) Endocrinology 142: 521-527.
Holst JJ, Deacon CF. (2004) Curr. Opin. Pharmacol. 4: 589-596.
Drucker DJ. (2002) Gastroenterology 122: 531- 544.
Kieffer TJ, McIntosh CH, Pederson RA. (1995) Endocrinology 136: 3585-3596.
Deacon CF, Nauck MA, Toft-Nielson M, Pridal L, Willms B, Holst JJ. (1995) Diabetes 44: 1126-1131.
Mentlein R. (1999) Regul. Pept. 85: 9-24.
Ahren B, Holst JJ, Martensson H, Balkan B. (2000) Eur. J. Pharmacol. 404: 239-245.
Deacon CF, Hughes TE, Holst JJ. (1998) Diabetes 47: 764-769.
Pospisilik JA, Stafford SG, Demuth HU, Brownsey R, Parkhous W, Finegood DT, McIntosh DH, Pederson RA.(2002) Diabetes 51: 943-950.
Deacon CF, Holst JJ. (2006) Int. J. Biochem. Cell Biol. 38: 831-844.
Triplitt C, Wright A, Chiquett E. (2006) Pharmacotherapy 26: 360-374.
Augustyns K, Van der Veken P, Haemers A. (2005) Expert Opin. Ther. Patents 15: 1387-1407.
Hunziker D, Hennig M, Peters, JU. Curr. Top. Med. Chem. 2005, 5, 1623-1637.
Villhauer EB, Brinkman JA, Naderi GB, Burkey BF, Dunning BE, Prasad K, Mangold BL, Russell ME, Hughes TE. (2003) J. Med. Chem. 46, 2774-2789.
Augeri DJ, Robl JA, Betebenner DA, Magnin DR, Khanna A, Robertson JG, Wang A, Simpkins LM, Taunk P, Huang Q, Han SP, Abboa-Offei B, Cap M Xin L, Tao L, Tozzo E, Welzel GE, Egan DM, Marcinkeviciene J, Chang SY, Biller SA, Kirby MS, Parker RA, Hamann LG. (2005) J. Med. Chem. 48: 5025-5037.
Feng J, Zhang Z, Wallace MB, Stafford JA, Kaldor SW, Kassel DB, Navre M, Shi L, Skene RJ, Asakawa T, Takeuchi K, Xu R, Webb DR, Gwaltney SL. (2007) J. Med. Chem. 50: 2297-2300.
Kim D, Wang L, Beconi M, Eiermann GJ, Fisher MH, He H, Hickey GJ, Kowalchick JE, Leiting B, Lyons K, Marsilio F, McCann ME, Patel RA, Petrov A, Scapin G, Patel SB, Roy RS, Wu JK, Wyvratt MJ, Zhang BB, Zhu, L, Thornberry NA, Weber AE. (2005) J. Med. Chem. 48: 141-151.
Kuhn B, Hennig M, Mattei P. (2007) Curr Top Med Chem. 7: 609-619.
Idris I, Donnelly R. (2007) Diabetes Obes Metab. 9: 153-165.
Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ. (1998) J Comput Chem 19: 1639-1662.
http://mgltools.scripps.edu/downloads
Ammirati MJ, Andrews KM, Boyer DD, Brodeur AM, Danley DE, Doran SD, Hulin B, Liu S, McPherson RK, Orena SJ, Parker JC, Polivkova J, Qiu X, Soglia CB, Treadway JL, VanVolkenburg MA, Wilder DC, Piotrowski DW. (2009) Bioorg Med. Chem. Lett. 19: 1991-1995.
Al-masri IM, Mohammad MK, Tahaa MO. (2009) Journal of Enzyme Inhibition and Medicinal Chemistry 24: 1061-1066.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright (c) 2020 Array